GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: HOE-901 | HOE901 | Lantus®
insulin glargine is an approved drug (FDA and EMA (2000))
Compound class:
Peptide
Comment: Insulin glargine is a recombinant, modified analogue of human insulin. The chemical structure shown here was generated using the SMILES from PubChem CID 44146714.
A number of insulin glargine biosimilars have been approved internationally since the expiration of patents on Lantus® in 2014: a comprehensive list that is maintained by the Generics and Biosimilar Initiative (https://www.gabionline.net) is available here. The first fully interchangeable biosimilar to be FDA approved was Semglee® (insulin glargine-yfgn; Mylan Pharmaceuticals), in July 2021. View more information in the IUPHAR Pharmacology Education Project: glargine |
|
|||||||||||||||
Classification ![]() |
|
| Compound class | Peptide |
| Approved drug? | Yes. EU EMA (2000) | US FDA (2000) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7548 | insulin glargine |
Synonyms ![]() |
| HOE-901 | HOE901 | Lantus® |
Database Links ![]() |
|
| CAS Registry No. | 160337-95-1 |
| ChEMBL Ligand | CHEMBL1201497 |
| DrugBank Ligand | DB00047 |
| GtoPdb PubChem SID | 223365908 |
| PubChem CID | 44146714 |
| Search Google for chemical match using the InChIKey | COCFEDIXXNGUNL-RFKWWTKHSA-N |
| Search Google for chemicals with the same backbone | COCFEDIXXNGUNL |
| Search PubMed clinical trials | insulin glargine |
| Search PubMed titles | insulin glargine |
| Search PubMed titles/abstracts | insulin glargine |
| UniChem Compound Search for chemical match using the InChIKey | COCFEDIXXNGUNL-RFKWWTKHSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | COCFEDIXXNGUNL-RFKWWTKHSA-N |
| Wikipedia | Insulin glargine |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Insulin glargine (links to external site)
Cat. No. HY-108719 |